<DOC>
	<DOCNO>NCT01776567</DOCNO>
	<brief_summary>The purpose trial directly compare Cobalt Chromium platform everolimus-eluting stent , Xience Prime™ , Platinum Chromium platform everolimus-eluting stent , Promus Element™ , relation stent scaffold shape , position heart blood vessel extent tissue coverage ( 6 month ) use optical coherence tomography . Hypotheses : 1 . The alloy composition strut design drug-eluting stent direct bearing stent apposition measure use OCT. 2 . Stent design alloy composition direct influence radial support scaffold shrinkage .</brief_summary>
	<brief_title>Apposition Assessed Using Optical Coherence Tomography Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Symptomatic coronary artery disease include patient chronic stable angina , silent ischemia , acute coronary syndrome include nonST elevation myocardial infarction 3 . Presence one coronary artery stenosis &gt; 50 % native coronary artery reference diameter range 2.25 4.25 mm cover one multiple stents 4 . No limitation number treat lesion number vessel accord randomization group 5 . Denovo native coronary disease complex lesion involve : Bifurcations , chronic occlusion &gt; 3 month , lesion &gt; 20mm length moderately/heavily calcify lesion length 1 . Known intolerance aspirin , clopidogrel , heparin , cobalt chromium , platinum chromium , everolimus , contrast material 2 . Acute STsegment elevation myocardial infarction 3 . Type A lesion include vessel angulation &lt; 45 degree 4 . Bypass graft 5 . Inability provide inform consent 6 . Pregnancy 7 . Planned surgery within 12 month PCI unless dual antiplatelet therapy maintain throughout perisurgical period 8 . Left ventricular ejection fraction &lt; 25 % 9 . Serum creatinine &gt; 180mmol/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>stent</keyword>
	<keyword>optical imaging</keyword>
</DOC>